-
-
-
-
-
-
-
CareDx, Inc (CDNA) PT Raised to $45 at BTIG
-
-
-
-
-
-
-
CareDx, Inc (CDNA) PT Raised to $28 at BTIG
-
-
-
-
-
-
-
CareDx reports clinical validation of AlloHeme cancer surveillance test
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on CareDx, Inc (CDNA)
-
-
-
-
-
-
-
CareDx launches AI-powered transplant diagnostic platform AlloSure Plus
-
-
-
-
-
-
-
CareDx (CDNA) Announces District Court Reverses Jury Decision in Patent Infringement Case Overturning Prior $96M Verdict
-
-
-
-
-
-
-
CareDx (CDNA) Tops Q3 EPS by 39c, Beats on Revenue; Offers FY24 Revenue Guidance
-
481,366 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


